Harper JC - Search Results

1

Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.

Harper JC, Roberts WE, Zeichner JA, Guenin E, Bhatt V, Pillai R. Harper JC, et al. J Dermatolog Treat. 2020 Mar;31(2):160-167. doi: 10.1080/09546634.2019.1587884. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30935257 Free article. Clinical Trial.

2

Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light.

Del Rosso JQ, Harper J, Pillai R, Moore R. Del Rosso JQ, et al. J Clin Aesthet Dermatol. 2012 Jan;5(1):27-9. J Clin Aesthet Dermatol. 2012. PMID: 22328956 Free PMC article.

3

Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.

Harper JC. Harper JC. J Drugs Dermatol. 2012 Dec;11(12):1440-5. J Drugs Dermatol. 2012. PMID: 23377514 Clinical Trial.

4

Tretinoin photostability: comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light.

Rosso JD, Harper J, Pillai R, Moore R. Rosso JD, et al. J Clin Aesthet Dermatol. 2013 Feb;6(2):25-8. J Clin Aesthet Dermatol. 2013. PMID: 23441237 Free PMC article.

5

Total Defense + Repair: A Novel Concept in Solar Protection and Skin Rejuvenation.

McDaniel DH, Hamzavi IH, Zeichner JA, Fabi SG, Bucay VW, Harper JC, Comstock JA, Makino ET, Mehta RC, Vega VL. McDaniel DH, et al. Among authors: harper jc. J Drugs Dermatol. 2015 Jul;14(7):s3-11. J Drugs Dermatol. 2015. PMID: 26151795

6

Treating Acne in Patients With Skin of Color.

Alexis AF, Harper JC, Stein Gold LF, Tan JKL. Alexis AF, et al. Among authors: harper jc. Semin Cutan Med Surg. 2018 Jun;37(3S):S71-S73. doi: 10.12788/j.sder.2018.027. Semin Cutan Med Surg. 2018. PMID: 30192346

7

Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.

Lain E, Day D, Harper J, Guenin E. Lain E, et al. J Drugs Dermatol. 2019 Nov 1;18(11):1128-1138. J Drugs Dermatol. 2019. PMID: 31741356 Clinical Trial.

8

Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.

Harper JC, Baldwin H, Stein Gold L, Guenin E. Harper JC, et al. J Drugs Dermatol. 2019 Nov 1;18(11):1147-1154. J Drugs Dermatol. 2019. PMID: 31741360 Clinical Trial.

9

Acne vulgaris: What's new in our 40th year.

Harper JC. Harper JC. J Am Acad Dermatol. 2020 Feb;82(2):526-527. doi: 10.1016/j.jaad.2019.01.092. Epub 2019 Dec 16. J Am Acad Dermatol. 2020. PMID: 31859048 No abstract available.

10

The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris.

Tyring SK, Kircik L, Pariser DM, Woolery-Lloyd HC, Harper JC, Bhatt V, Pillai R, Guenin E. Tyring SK, et al. Among authors: harper jc. Am J Clin Dermatol. 2020 Dec;21(6):891-899. doi: 10.1007/s40257-020-00559-3. Am J Clin Dermatol. 2020. PMID: 32886337 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters